mazdutide and tirzepatide together (IBI362): The Next-Generation Dual GLP-1/Glucagon Agonist for Obesity Metabolic Health Mazdutide: An emerging glucagon/GCG-like peptide-1
Description
Dose Level: Higher Strengths Often Produce Bigger Drops Weight loss on Tirzepatide is dose-dependent
Same 2.5 mg dose, but your vial reads 5 mg/mL
Companies prioritize high-margin sales to affluent, well-insured markets, aligning with shareholder interests rather than public health goals
Adding more water makes the solution weaker
At the standard 10 mg/mL concentration, these deliver 2 mg and 2.5 mg respectively
